Biomaterial Database

Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study. 2009

Vanda Markovic-Pekovic, and Svjetlana Stoisavljevic-Satara, and Ranko Skrbic

Health Insurance Fund, Republic of Srpska, Banja Luka, Bosnia and Herzegovina.

OBJECTIVE The objective of this study was to analyse cardiovascular medicines utilisation patterns in Republic of Srpska (Bosnia and Herzegovina) over the 2002-2006 period. METHODS A retrospective study was taken to analyse utilisation medicines reimbursed by the Health Insurance Fund (HIF), with a focus on cardiovascular medicines utilisation. ATC/DDD methodology was used to monitor utilisation of medicines. Drug utilisation 90% (DU90%) method was used to determine the prescribing quality of cardiovascular medicines. RESULTS Utilisation of cardiovascular medicines accounted for more than one half of the total medicines utilisation, with an increasing trend. Most prescribed were antihypertensive medicines i.e. ACE inhibitors, both plain and in combination with thiazide diuretics, and calcium channel blockers (CCB). Utilisation of beta-blockers and thiazide diuretics remains rather low despite an overall increase in utilisation. Re-introduction of statins in 2004 instantly led to high utilisation. The number of cardiovascular medicines within DU90% segment varies from 8 in 2002 to 12 in 2006. CONCLUSIONS This study showed a constant increase in total medicines utilisation with the cardiovascular medicines as the most prescribed. DU90% is shown as a simple method for assessing general quality of medicines prescribing, which indicated that better adherence to the guidelines is needed in order to practice a more rational use of medicines and a cost-efficient use of all resources. More stratified routinely performed analyses are also needed.

UI	MeSH Term	Description	Entries
D007349	Insurance, Health, Reimbursement	Payment by a third-party payer in a sum equal to the amount expended by a health care provider or facility for health services rendered to an insured or program beneficiary. (From Facts on File Dictionary of Health Care Management, 1988)	Health Insurance Reimbursement,Reimbursement, Health Insurance,Third-Party Payments,Third-Party Payers,Health Insurance Reimbursements,Insurance Reimbursement, Health,Insurance Reimbursements, Health,Payer, Third-Party,Payers, Third-Party,Payment, Third-Party,Payments, Third-Party,Reimbursements, Health Insurance,Third Party Payers,Third Party Payments,Third-Party Payer,Third-Party Payment
D007356	Insurance, Pharmaceutical Services	Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.	Drug Benefit Plans,Drug Insurance,Prescription Insurance,Insurance, Pharmaceutic Services,Insurance, Pharmacy Services,Pharmaceutic Services Insurance,Pharmaceutical Services Insurance,Pharmacy Services Insurance,Drug Benefit Plan,Insurance, Drug,Insurance, Prescription,Plan, Drug Benefit,Plans, Drug Benefit
D010818	Practice Patterns, Physicians'	Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.	Clinical Practice Patterns,Physician's Practice Patterns,Clinical Practice Pattern,Pattern, Clinical Practice,Patterns, Clinical Practice,Practice Pattern, Clinical,Practice Patterns, Clinical,Practice Patterns, Physician's,Prescribing Patterns, Physician,Physician Practice Patterns,Physician Prescribing Pattern,Physician Prescribing Patterns,Physician's Practice Pattern,Physicians' Practice Pattern,Physicians' Practice Patterns,Practice Pattern, Physician's,Practice Pattern, Physicians',Practice Patterns, Physician,Prescribing Pattern, Physician
D011307	Drug Prescriptions	Directions written for the obtaining and use of DRUGS.	Drug Prescribing,Drug Prescription,Drug Prescribings,Prescribing, Drug,Prescribings, Drug
D002317	Cardiovascular Agents	Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.	Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D004363	Drug Utilization	The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.	Utilization, Drug,Drug Utilizations,Utilizations, Drug
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189	Retrospective Studies	Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.	Retrospective Study,Studies, Retrospective,Study, Retrospective
D013997	Time Factors	Elements of limited time intervals, contributing to particular results or situations.	Time Series,Factor, Time,Time Factor
D017410	Practice Guidelines as Topic	Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.	Clinical Guidelines as Topic,Best Practices,Best Practice